KAI-1678 is under investigation in clinical trial NCT01106716 (Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.